Fanciulli A, Sixel-Doring F, Buhmann C, Krismer F, Hermann W, Winkler C
J Neurol. 2025; 272(1):90.
PMID: 39751950
PMC: 11698777.
DOI: 10.1007/s00415-024-12730-5.
Liu H, Wang X
Neuropsychiatr Dis Treat. 2024; 20:2585-2591.
PMID: 39723118
PMC: 11669284.
DOI: 10.2147/NDT.S495092.
Oh E, Cheon S, Cho J, Sung Y, Kim J, Shin H
J Neural Transm (Vienna). 2024; 132(3):431-441.
PMID: 39540934
PMC: 11870872.
DOI: 10.1007/s00702-024-02851-6.
Gandhi P, Tangamornsuksan W, Couban R, Guyatt G, Steele C, Marras C
Dysphagia. 2024; .
PMID: 39305303
DOI: 10.1007/s00455-024-10755-6.
Shi Y, Ma J, Li S, Liu C, Liu Y, Chen J
Signal Transduct Target Ther. 2024; 9(1):238.
PMID: 39256355
PMC: 11387494.
DOI: 10.1038/s41392-024-01929-7.
Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis.
Cox E, Wade R, Hodgson R, Fulbright H, Phung T, Meader N
Health Technol Assess. 2024; 28(30):1-187.
PMID: 39021200
PMC: 11331379.
DOI: 10.3310/YDSL3294.
Skull Density Ratio as Arm-Allocation Parameter for a Controlled Focused Ultrasound Trial in Parkinson's Disease.
Pineda-Pardo J, Martinez-Fernandez R, Natera-Villalba E, Ruiz-Yanzi A, Rodriguez-Rojas R, Del Alamo M
Mov Disord Clin Pract. 2024; 11(7):825-829.
PMID: 38741245
PMC: 11233930.
DOI: 10.1002/mdc3.14040.
Levodopa-Entacapone-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson's Disease: A Single Center Real-World Experience.
Szatmari S, Szasz J, Orban-Kis K, Baroti B, Bataga S, Ciorba M
Pharmaceutics. 2024; 16(4).
PMID: 38675114
PMC: 11053778.
DOI: 10.3390/pharmaceutics16040453.
Advanced Parkinson's disease treatment patterns in Italy: an observational study interim analysis.
Stocchi F, Barone P, Ceravolo R, De Pandis M, Lopiano L, Modugno N
Ann Med. 2024; 56(1):2315226.
PMID: 38381654
PMC: 10883087.
DOI: 10.1080/07853890.2024.2315226.
Starting with 24-h levodopa carbidopa intestinal gel at initiation in a large cohort of advanced Parkinson's disease patients.
Szatmari S, Szasz J, Orban-Kis K, Bataga S, Ciorba M, Nagy E
Sci Rep. 2024; 14(1):3676.
PMID: 38355970
PMC: 10867013.
DOI: 10.1038/s41598-024-54299-z.
Gender gap in deep brain stimulation for Parkinson's disease: preliminary results of a retrospective study.
Somma T, Bove I, Vitulli F, Solari D, Bocchino A, Palmiero C
Neurosurg Rev. 2024; 47(1):63.
PMID: 38263479
PMC: 10806036.
DOI: 10.1007/s10143-024-02290-7.
How to Use the New European Academy of Neurology/Movement Disorder Society European Section Guideline for Invasive Therapies in Parkinson's Disease.
Brinker D, Smilowska K, Paschen S, Antonini A, Moro E, Deuschl G
Mov Disord Clin Pract. 2024; 11(3):209-219.
PMID: 38214401
PMC: 10928336.
DOI: 10.1002/mdc3.13962.
Management of OFF condition in Parkinson disease.
Koch J
Ment Health Clin. 2023; 13(6):289-297.
PMID: 38058599
PMC: 10696172.
DOI: 10.9740/mhc.2023.12.289.
End of life care of hospitalized patients with Parkinson disease: a retrospective analysis and brief review.
Bhansali S, Assaedi E, Yu J, Mandava N, Sonneborn C, Hogue O
Front Aging Neurosci. 2023; 15:1265156.
PMID: 37744391
PMC: 10511646.
DOI: 10.3389/fnagi.2023.1265156.
Antiparkinsonian medication masks motor signal progression in de novo patients.
Brzezicki M, Conway N, Sotirakis C, FitzGerald J, Antoniades C
Heliyon. 2023; 9(6):e16415.
PMID: 37265609
PMC: 10230196.
DOI: 10.1016/j.heliyon.2023.e16415.
Clinical Use of On-Demand Therapies for Patients with Parkinson's Disease and OFF Periods.
Pahwa R, Pagan F, Kremens D, Saint-Hilaire M
Neurol Ther. 2023; 12(4):1033-1049.
PMID: 37221354
PMC: 10310675.
DOI: 10.1007/s40120-023-00486-5.
Safinamide as an Adjunct to Levodopa in Asian and Caucasian Patients With Parkinson's Disease and Motor Fluctuations: A Post Hoc Analysis of the SETTLE Study.
Bhidayasiri R, Ishida T, Kamei T, Husni R, Suzuki I, Wu S
J Mov Disord. 2023; 16(2):180-190.
PMID: 37096301
PMC: 10236023.
DOI: 10.14802/jmd.22196.
The PPN and motor control: Preclinical studies to deep brain stimulation for Parkinson's disease.
Lin C, Ridder M, Sah P
Front Neural Circuits. 2023; 17:1095441.
PMID: 36925563
PMC: 10011138.
DOI: 10.3389/fncir.2023.1095441.
Pharmacological Treatment of Tremor in Parkinson's Disease Revisited.
Pirker W, Katzenschlager R, Hallett M, Poewe W
J Parkinsons Dis. 2023; 13(2):127-144.
PMID: 36847017
PMC: 10041452.
DOI: 10.3233/JPD-225060.
The Effectiveness and Toxicity of Frameless CyberKnife Based Radiosurgery for Parkinson's Disease-Phase II Study.
Goc B, Roch-Zniszczol A, Larysz D, Zarudzki L, Stapor-Fudzinska M, Rozek A
Biomedicines. 2023; 11(2).
PMID: 36830825
PMC: 9952894.
DOI: 10.3390/biomedicines11020288.